Home | All trials

[RDF data]
Trial NCT00000324

Resource URI: http://static.linkedct.org/resource/trials/NCT00000324
PropertyValue
linkedct:brief_title Tryptophan and Behavior Therapy for Cocaine Abuse - 1
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/4243>
linkedct:condition <http://static.linkedct.org/resource/condition/2992>
linkedct:criteria Inclusion Criteria: - Cocaine dependent Exclusion Criteria: - Physically dependent on drugs of abuse other than cocaine - Significant medical or psychiatric illness (besides substance abuse disorder) - Pregnant
linkedct:description This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using a relapse prevention model of treatment intervention.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 55 Years
linkedct:eligibility_minimum_age 18 Years
linkedct:end_date April 2001
linkedct:enrollment 200 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000324
rdfs:label Trial NCT00000324
linkedct:lastchanged_date November 3, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/163296>
linkedct:nct_id NCT00000324
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Tryptophan and Behavior Therapy for Cocaine Abuse
linkedct:org_study_id NIDA-10754-1
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/16643>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2920>
foaf:page <http://clinicaltrials.gov/show/NCT00000324>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/14439>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/17505>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/19100>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/20454>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4858>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4862>
linkedct:reference <http://static.linkedct.org/resource/reference/1820>
linkedct:reference <http://static.linkedct.org/resource/reference/26022>
linkedct:secondary_id R01-10754-1
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date March 1997
linkedct:study_design Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.
rdf:type linkedct:trials
linkedct:verification_date August 2005